Taiko Pharmaceutical 

¥255
4
+¥1+0.39% Friday 06:30

Statistics

Day High
255
Day Low
251
52W High
322
52W Low
246
Volume
92,400
Avg. Volume
113,134
Mkt Cap
12.91B
P/E Ratio
-
Dividend Yield
2.75%
Dividend
7

Upcoming

Dividends

2.75%Dividend Yield
Mar 26
¥3
Mar 21
¥8
Mar 21
¥10
Dec 20
¥7
Jun 20
¥7
10Y Growth
-4.07%
5Y Growth
-27.95%
3Y Growth
N/A
1Y Growth
N/A

Earnings

6NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1.88
1.44
4.76
8.08
Expected EPS
N/A
Actual EPS
N/A

Financials

1.67%Profit Margin
Profitable
2021
2022
2023
2024
2025
2026
2.64BRevenue
44MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4574.TSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited is a major competitor in the pharmaceutical industry, offering a wide range of products that compete with Taiko Pharmaceutical's offerings.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. specializes in prescription pharmaceuticals, directly competing in the same market segments as Taiko Pharmaceutical.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. is known for its research and development in the pharmaceutical field, making it a strong competitor in areas overlapping with Taiko's interests.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited operates in similar therapeutic areas as Taiko Pharmaceutical, making them direct competitors.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. focuses on innovative drug discovery, competing with Taiko Pharmaceutical in the development of new pharmaceuticals.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. is involved in the manufacture and sale of pharmaceuticals, competing with Taiko Pharmaceutical in various therapeutic areas.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. is a competitor due to its broad range of pharmaceutical products that overlap with Taiko Pharmaceutical's market.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse portfolio of pharmaceutical products, making it a competitor in several of Taiko Pharmaceutical's key areas.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. competes with Taiko Pharmaceutical in the pharmaceutical sector, particularly in the development and marketing of prescription drugs.
Ono Pharmaceutical
4528.TSE
Mkt Cap1.65T
Ono Pharmaceutical Co., Ltd. is a competitor due to its focus on drug discovery and development in areas that potentially overlap with Taiko Pharmaceutical's interests.

About

Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.
Show more...
CEO
Takashi Shibata
Employees
220
Country
Japan
ISIN
JP3442200006

Listings

0 Comments

Share your thoughts

FAQ

What is Taiko Pharmaceutical stock price today?
The current price of 4574.TSE is ¥255 JPY — it has increased by +0.39% in the past 24 hours. Watch Taiko Pharmaceutical stock price performance more closely on the chart.
What is Taiko Pharmaceutical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Taiko Pharmaceutical stocks are traded under the ticker 4574.TSE.
Is Taiko Pharmaceutical stock price growing?
4574.TSE stock has fallen by -3.04% compared to the previous week, the month change is a +3.24% rise, over the last year Taiko Pharmaceutical has showed a -18.01% decrease.
What is Taiko Pharmaceutical market cap?
Today Taiko Pharmaceutical has the market capitalization of 12.91B
When is the next Taiko Pharmaceutical earnings date?
Taiko Pharmaceutical is going to release the next earnings report on November 06, 2026.
What were Taiko Pharmaceutical earnings last quarter?
4574.TSE earnings for the last quarter are 2.73 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Taiko Pharmaceutical revenue for the last year?
Taiko Pharmaceutical revenue for the last year amounts to 2.64B JPY.
What is Taiko Pharmaceutical net income for the last year?
4574.TSE net income for the last year is 44M JPY.
Does Taiko Pharmaceutical pay dividends?
Yes, 4574.TSE dividends are paid semi-annual. The last dividend per share was 3.3 JPY. As of today, Dividend Yield (FWD)% is 2.75%.
How many employees does Taiko Pharmaceutical have?
As of September 05, 2026, the company has 220 employees.
In which sector is Taiko Pharmaceutical located?
Taiko Pharmaceutical operates in the Health & Wellness sector.
When did Taiko Pharmaceutical complete a stock split?
The last stock split for Taiko Pharmaceutical was on March 30, 2020 with a ratio of 3:1.
Where is Taiko Pharmaceutical headquartered?
Taiko Pharmaceutical is headquartered in Osaka, Japan.